Moreover, the SM group had a significantly higher baseline score on the 21-item revised Beck Depression Inventory (BDI-IA) scale compared to the FM group, reinforcing the association between the CYP2C19 gene and MDD patients’ clinical characteristics. This evidence concerns the gene CYP2C19 and major depressive disorder.